Speaker illustration

Doctor Florian Wenzl

University of Zurich, Zurich (Switzerland)

Member of:

European Society of Cardiology
European Society of Cardiology

Florian Wenzl MD completed his postgraduate training at the University of Pennsylvania and continued his cardiology fellowship at the German Heart Centre Munich before joining the University of Zurich in 2021. Florian and his team are based in Zurich and focus on risk prediction modelling and biomarker research to refine personalised treatment approaches. He received numerous prizes and awards for his engagement in research and teaching including the Ars Docendi National Prize awarded by the Austrian Minister of Education, the ESC Young Investigator Award, and the FAN Award for Medicine and Natural Sciences awarded by the University of Zurich. Florian is Honorary Fellow of the University of Leicester, fellow of the SPUM-ACS and MINAP cohorts, and serves in the steering committee of the Swiss National Registry of Myocardial Infarction (AMIS Plus).

Validation of the GRACE 3.0 score and redefinition of the risk threshold for early invasive treatment in non-ST-segment elevation acute coronary syndromes: a modelling study from five countries

Event: ESC Congress 2023

Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)

Session: Risk stratification in acute coronary syndromes (4)

Thumbnail

Circulating dipeptidyl peptidase 3 predicts hemodynamic impairment and premature death in acute coronary syndromes: insights from the prospective multicenter SPUM-ACS study

Event: ESC Congress 2023

Topic: Clinical

Session: Young Investigator Awards Session in Clinical Cardiology

Thumbnail

Sex inequities in the performance of the GRACE 2.0 score in non-ST-segment elevation acute coronary syndromes: a multinational observational study in contemporary cohorts from four European countries

Event: ESC Congress 2022

Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)

Session: What defines risk in acute coronary syndromes

Thumbnail

Bleeding risk in patients hospitalized for non-ST-segment elevation acute coronary syndromes in Switzerland: performance of the CRUSADE score

Event: ESC Congress 2022

Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)

Session: What defines risk in acute coronary syndromes

Thumbnail

Remnant cholesterol contributes to residual lipid risk after acute coronary syndromes

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease - Epidemiology, prognosis, outcome 5

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb